Parkinsonism and Related Disorders, ISSN 1353-8020, 04/2018, Volume 49, pp. 106 - 107
Journal Article
Jama : Journal of the American Medical Association, ISSN 0098-7484, 2015, Volume 313, Issue 19, pp. 1924 - 1938
IMPORTANCE: Cerebral amyloid-beta aggregation is an early pathological event in Alzheimer disease (AD), starting decades before dementia onset. Estimates of...
OLDER PERSONS | POPULATION | MEDICINE, GENERAL & INTERNAL | CEREBROSPINAL-FLUID BIOMARKERS | COHORT | MILD COGNITIVE IMPAIRMENT | DIAGNOSTIC-CRITERIA | BETA-AMYLOIDOSIS | ASSOCIATION | PIB PET | ALZHEIMER-DISEASE PATHOLOGY | Apolipoprotein E4 - genetics | Dementia - pathology | Prevalence | Age Factors | Humans | Middle Aged | Risk Factors | Biomarkers - analysis | Genotype | Male | Positron-Emission Tomography | Cognitive Dysfunction - pathology | Cerebrospinal Fluid - chemistry | Aged, 80 and over | Amyloid beta-Peptides - analysis | Brain - pathology | Adult | Female | Aged | Usage | Analysis | Amyloidosis | Cognition | Research | Biological markers | Risk factors | Meta-analysis | Prevalence studies (Epidemiology) | Pathology | Medical research | Neurological disorders | Dementia | Brain | Neurosciences | pathology | Biological Markers | 80 and over | genetics | Amyloid beta-Peptides | Neurovetenskaper | chemistry | Apolipoprotein E4 | Cerebrospinal Fluid | analysis | Mild Cognitive Impairment
OLDER PERSONS | POPULATION | MEDICINE, GENERAL & INTERNAL | CEREBROSPINAL-FLUID BIOMARKERS | COHORT | MILD COGNITIVE IMPAIRMENT | DIAGNOSTIC-CRITERIA | BETA-AMYLOIDOSIS | ASSOCIATION | PIB PET | ALZHEIMER-DISEASE PATHOLOGY | Apolipoprotein E4 - genetics | Dementia - pathology | Prevalence | Age Factors | Humans | Middle Aged | Risk Factors | Biomarkers - analysis | Genotype | Male | Positron-Emission Tomography | Cognitive Dysfunction - pathology | Cerebrospinal Fluid - chemistry | Aged, 80 and over | Amyloid beta-Peptides - analysis | Brain - pathology | Adult | Female | Aged | Usage | Analysis | Amyloidosis | Cognition | Research | Biological markers | Risk factors | Meta-analysis | Prevalence studies (Epidemiology) | Pathology | Medical research | Neurological disorders | Dementia | Brain | Neurosciences | pathology | Biological Markers | 80 and over | genetics | Amyloid beta-Peptides | Neurovetenskaper | chemistry | Apolipoprotein E4 | Cerebrospinal Fluid | analysis | Mild Cognitive Impairment
Journal Article
Journal of Neurology, ISSN 0340-5354, 11/2019, Volume 266, Issue 11, pp. 2710 - 2717
Delirium is a very common neurobehavioral complication after stroke, but its influence on long-term outcome is not well characterized. The objective of the...
Delirium | Long-term prognosis | Neurology | Neurosciences | Stroke | Medicine & Public Health | Mortality | Neuroradiology | Neurological diseases | Nursing homes | Nursing | Prognosis | Respiratory diseases | Propolis | Patients | Risk factors | Original Communication
Delirium | Long-term prognosis | Neurology | Neurosciences | Stroke | Medicine & Public Health | Mortality | Neuroradiology | Neurological diseases | Nursing homes | Nursing | Prognosis | Respiratory diseases | Propolis | Patients | Risk factors | Original Communication
Journal Article
Journal of Neurology, ISSN 0340-5354, 4/2018, Volume 265, Issue 4, pp. 863 - 870
Delirium is the most common and serious neurobehavioral complication in acute hospital admissions. Some patients develop signs of delirium but do not meet all...
Delirium | Neurology | Neurosciences | Stroke | Medicine & Public Health | Subsyndromal delirium | Neuroradiology | RISK-FACTORS | DEMENTIA | VALIDATION | SYMPTOMS | PREVALENCE | CLINICAL NEUROLOGY | COGNITIVE TEST | CONFUSION ASSESSMENT METHOD | ACUTE STROKE | SCALE | Severity of Illness Index | Delirium - epidemiology | Delirium - etiology | Prospective Studies | Humans | Middle Aged | Risk Factors | Stroke - complications | Male | Aged, 80 and over | Female | Stroke - epidemiology | Aged | Causality | Delirium - diagnosis | Stroke (Disease) | Diagnosis | Management | Hospital care | Risk factors | Urinary tract | Propolis | Cognitive ability
Delirium | Neurology | Neurosciences | Stroke | Medicine & Public Health | Subsyndromal delirium | Neuroradiology | RISK-FACTORS | DEMENTIA | VALIDATION | SYMPTOMS | PREVALENCE | CLINICAL NEUROLOGY | COGNITIVE TEST | CONFUSION ASSESSMENT METHOD | ACUTE STROKE | SCALE | Severity of Illness Index | Delirium - epidemiology | Delirium - etiology | Prospective Studies | Humans | Middle Aged | Risk Factors | Stroke - complications | Male | Aged, 80 and over | Female | Stroke - epidemiology | Aged | Causality | Delirium - diagnosis | Stroke (Disease) | Diagnosis | Management | Hospital care | Risk factors | Urinary tract | Propolis | Cognitive ability
Journal Article
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, ISSN 1552-5260, 07/2018, Volume 14, Issue 7, pp. P776 - P776
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 02/2016, Volume 50, Issue 3, pp. 623 - 644
Journal Article
Neurologia i Neurochirurgia Polska, ISSN 0028-3843, 05/2016, Volume 50, Issue 3, pp. 215 - 218
Neurologic involvement is well recognized in Systemic Scleroderma and increasingly reported in Localized Scleroderma. MRI brain abnormalities are often...
Magnetic Resonance Imaging | Neurocutaneous Syndrome | Facial hemiatrophy | Mild Cognitive Impairment | Parry-Romberg Syndrome | Localized Scleroderma | ATROPHY | INVOLVEMENT | WHITE-MATTER LESION | EN-COUP | NEUROIMAGING FINDINGS | CLINICAL NEUROLOGY | CHILDREN | SABRE | MANIFESTATIONS | Young Adult | Brain Diseases - pathology | Scleroderma, Localized - complications | Humans | Atrophy - pathology | Adult | Facial Hemiatrophy - complications | Female | Atrophy - etiology | Brain Diseases - etiology | Cognitive Dysfunction - etiology | Temporal Lobe - pathology
Magnetic Resonance Imaging | Neurocutaneous Syndrome | Facial hemiatrophy | Mild Cognitive Impairment | Parry-Romberg Syndrome | Localized Scleroderma | ATROPHY | INVOLVEMENT | WHITE-MATTER LESION | EN-COUP | NEUROIMAGING FINDINGS | CLINICAL NEUROLOGY | CHILDREN | SABRE | MANIFESTATIONS | Young Adult | Brain Diseases - pathology | Scleroderma, Localized - complications | Humans | Atrophy - pathology | Adult | Facial Hemiatrophy - complications | Female | Atrophy - etiology | Brain Diseases - etiology | Cognitive Dysfunction - etiology | Temporal Lobe - pathology
Journal Article
Clinical Neurophysiology, ISSN 1388-2457, 2014, Volume 125, pp. S196 - S197
Journal Article
American Journal of Alzheimer's Disease & Other Dementias, ISSN 1533-3175, 12/2014, Volume 29, Issue 8, pp. 732 - 734
Introduction: Mutations in the gene for presenilin 1 (PSEN-1) cause familial, early-onset Alzheimer’s disease (EOAD). Diagnosis of EOAD is often a challenge...
Journal Article
The Journal of Neuropsychiatry and Clinical Neurosciences, ISSN 0895-0172, 4/2019, Volume 31, Issue 2, pp. 104 - 111
Objective:Although delirium is the most common neurobehavioral complication after stroke, its motor subtypes—hypoactive, hyperactive, mixed, and none—as well...
DEMENTIA | CONFUSION ASSESSMENT METHOD | PSYCHIATRY | ACUTE ISCHEMIC-STROKE | OUTCOMES | SCALE | NURSES RECOGNITION | ASSOCIATION | NEUROSCIENCES | SEVERITY | CLINICAL NEUROLOGY
DEMENTIA | CONFUSION ASSESSMENT METHOD | PSYCHIATRY | ACUTE ISCHEMIC-STROKE | OUTCOMES | SCALE | NURSES RECOGNITION | ASSOCIATION | NEUROSCIENCES | SEVERITY | CLINICAL NEUROLOGY
Journal Article
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, ISSN 1426-9686, 09/2018, Volume 45, Issue 267, p. 107
Depressive and anxiety disorders among people with epilepsy are more common than in general population and they are associated with less efficient emotion...
Epilepsy - psychology | Humans | Middle Aged | Depression | Male | Treatment Outcome | Cognitive Behavioral Therapy | Epilepsy - physiopathology | Young Adult | Galvanic Skin Response | Adolescent | Adult | Female | Surveys and Questionnaires | Aged | Anxiety | Epilepsy - therapy
Epilepsy - psychology | Humans | Middle Aged | Depression | Male | Treatment Outcome | Cognitive Behavioral Therapy | Epilepsy - physiopathology | Young Adult | Galvanic Skin Response | Adolescent | Adult | Female | Surveys and Questionnaires | Aged | Anxiety | Epilepsy - therapy
Journal Article
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, ISSN 1426-9686, 09/2018, Volume 45, Issue 267, pp. 107 - 113
Journal Article
Journal of the American Geriatrics Society, ISSN 0002-8614, 04/2011, Volume 59, Issue 4, p. 757
Journal Article
Journal of the American Geriatrics Society, ISSN 0002-8614, 04/2011, Volume 59, Issue 4, pp. 757 - 759
Journal Article
Cognitive and Behavioral Neurology, ISSN 1543-3633, 12/2016, Volume 29, Issue 4, pp. 174 - 189
Delirium is a transient condition characterized by sudden and fluctuating disturbances in cognitive function. The condition can be considered a sign of the...
stroke | delirium | acute confusion | RISK-FACTORS | INFORMANT QUESTIONNAIRE | COGNITIVE IMPAIRMENT | ACUTE CONFUSIONAL STATE | CLINICAL NEUROLOGY | SYSTEMIC INFLAMMATION | ANTIPSYCHOTIC MEDICATION | POSTOPERATIVE DELIRIUM | INTRACEREBRAL HEMORRHAGE | BEHAVIORAL SCIENCES | ELDERLY-PATIENTS | ISCHEMIC-STROKE | Delirium - psychology | Delirium - complications | Stroke - psychology | Humans | Risk Factors | Stroke - complications | Female | Psychometrics
stroke | delirium | acute confusion | RISK-FACTORS | INFORMANT QUESTIONNAIRE | COGNITIVE IMPAIRMENT | ACUTE CONFUSIONAL STATE | CLINICAL NEUROLOGY | SYSTEMIC INFLAMMATION | ANTIPSYCHOTIC MEDICATION | POSTOPERATIVE DELIRIUM | INTRACEREBRAL HEMORRHAGE | BEHAVIORAL SCIENCES | ELDERLY-PATIENTS | ISCHEMIC-STROKE | Delirium - psychology | Delirium - complications | Stroke - psychology | Humans | Risk Factors | Stroke - complications | Female | Psychometrics
Journal Article
Journal of the American Geriatrics Society, ISSN 0002-8614, 03/2013, Volume 61, Issue 3, p. 454
Journal Article
JAMA Psychiatry, ISSN 2168-622X, 2018, Volume 75, Issue 1, pp. 84 - 95
Importance: Cerebral amyloid-beta aggregation is an early event in Alzheimer disease (AD). Understanding the association between amyloid aggregation and...
INDIVIDUALS | LIFE-SPAN | MEMORY PERFORMANCE | METAANALYSIS | PSYCHIATRY | PRECLINICAL ALZHEIMERS-DISEASE | APOE | BURDEN | DECLINE | AGE | IMPAIRMENT | Alzheimer Disease - physiopathology | Cognition Disorders - physiopathology | Cross-Sectional Studies | Brain - physiopathology | Humans | Middle Aged | Memory, Episodic | Male | Reference Values | Mental Status and Dementia Tests | Positron-Emission Tomography | Cognitive Dysfunction - physiopathology | Alzheimer Disease - diagnosis | Cognition Disorders - diagnosis | Amyloid beta-Peptides - cerebrospinal fluid | Cognitive Dysfunction - psychology | Female | Aged | Cognitive Dysfunction - diagnosis | Alzheimer Disease - psychology | Cognition Disorders - psychology | Online First | Original Investigation | Research | Clinical Medicine | No dementia | Medical and Health Sciences | Medicin och hälsovetenskap | amyloid-β | cognitive functioning | Klinisk medicin | Geriatrik | Geriatrics
INDIVIDUALS | LIFE-SPAN | MEMORY PERFORMANCE | METAANALYSIS | PSYCHIATRY | PRECLINICAL ALZHEIMERS-DISEASE | APOE | BURDEN | DECLINE | AGE | IMPAIRMENT | Alzheimer Disease - physiopathology | Cognition Disorders - physiopathology | Cross-Sectional Studies | Brain - physiopathology | Humans | Middle Aged | Memory, Episodic | Male | Reference Values | Mental Status and Dementia Tests | Positron-Emission Tomography | Cognitive Dysfunction - physiopathology | Alzheimer Disease - diagnosis | Cognition Disorders - diagnosis | Amyloid beta-Peptides - cerebrospinal fluid | Cognitive Dysfunction - psychology | Female | Aged | Cognitive Dysfunction - diagnosis | Alzheimer Disease - psychology | Cognition Disorders - psychology | Online First | Original Investigation | Research | Clinical Medicine | No dementia | Medical and Health Sciences | Medicin och hälsovetenskap | amyloid-β | cognitive functioning | Klinisk medicin | Geriatrik | Geriatrics
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 02/2016, Volume 50, Issue 3, pp. 623 - 644
Alzheimer's disease (AD) is a neurodegenerative, inevitably progressive disease with a rate of cognitive, functional, and behavioral decline that varies highly...
progression | deterioration | cognitive decline | Alzheimer's disease | biomarkers | CSF BIOMARKERS PREDICT | CONVERTING ENZYME-INHIBITORS | 2-YEAR FOLLOW-UP | NEUROSCIENCES | POSITRON-EMISSION-TOMOGRAPHY | SLOWER COGNITIVE DECLINE | MENTAL-STATE-EXAMINATION | IN-VIVO | FUNCTIONAL DECLINE | CEREBRAL-BLOOD-FLOW | EXTRAPYRAMIDAL SIGNS | Biomarkers - metabolism | Neuroimaging | Humans | Alzheimer Disease - metabolism | Radionuclide Imaging | Alzheimer Disease - diagnostic imaging | Disease Progression | Alzheimer Disease - pathology
progression | deterioration | cognitive decline | Alzheimer's disease | biomarkers | CSF BIOMARKERS PREDICT | CONVERTING ENZYME-INHIBITORS | 2-YEAR FOLLOW-UP | NEUROSCIENCES | POSITRON-EMISSION-TOMOGRAPHY | SLOWER COGNITIVE DECLINE | MENTAL-STATE-EXAMINATION | IN-VIVO | FUNCTIONAL DECLINE | CEREBRAL-BLOOD-FLOW | EXTRAPYRAMIDAL SIGNS | Biomarkers - metabolism | Neuroimaging | Humans | Alzheimer Disease - metabolism | Radionuclide Imaging | Alzheimer Disease - diagnostic imaging | Disease Progression | Alzheimer Disease - pathology
Journal Article
Stroke, ISSN 0039-2499, 05/2012, Volume 43, Issue 5, pp. 1412 - 1414
Background and Purpose-Fibrin clot formation is important in acute intracerebral hemorrhage (ICH). We investigated plasma fibrin clot characteristics in acute...
Fibrinolysis | Fibrin clot | fibrinolysis | OXIDATIVE STRESS | PLASMA | PERMEABILITY | SUSCEPTIBILITY | INTRACEREBRAL HEMORRHAGE | LYSIS | PERIPHERAL VASCULAR DISEASE | fibrin clot | CLINICAL NEUROLOGY | Intracranial Thrombosis - pathology | Cerebral Hemorrhage - metabolism | Cerebral Hemorrhage - drug therapy | Fibrin Fibrinogen Degradation Products - metabolism | Humans | Middle Aged | Male | Treatment Outcome | Stroke - drug therapy | Tissue Plasminogen Activator - therapeutic use | Intracranial Thrombosis - metabolism | Stroke - pathology | Phenotype | Stroke - metabolism | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Female | Aged | Fibrin - metabolism | Cerebral Hemorrhage - pathology
Fibrinolysis | Fibrin clot | fibrinolysis | OXIDATIVE STRESS | PLASMA | PERMEABILITY | SUSCEPTIBILITY | INTRACEREBRAL HEMORRHAGE | LYSIS | PERIPHERAL VASCULAR DISEASE | fibrin clot | CLINICAL NEUROLOGY | Intracranial Thrombosis - pathology | Cerebral Hemorrhage - metabolism | Cerebral Hemorrhage - drug therapy | Fibrin Fibrinogen Degradation Products - metabolism | Humans | Middle Aged | Male | Treatment Outcome | Stroke - drug therapy | Tissue Plasminogen Activator - therapeutic use | Intracranial Thrombosis - metabolism | Stroke - pathology | Phenotype | Stroke - metabolism | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Female | Aged | Fibrin - metabolism | Cerebral Hemorrhage - pathology
Journal Article
Alzheimer's & Dementia, ISSN 1552-5260, 07/2016, Volume 12, Issue 7, p. P881
Journal Article